Liquid Biopsy Market Size, Share, By Offering (Instruments, Reagents & Kits, and software and services), Biomarker (Circulating Tumor (CTC), Circulating Nucleic Acids, Exosomes, Circulating Biomarkers and Others), Technology (Next-generation Sequencing (NGS), and Polymerase Chain Reaction (PCR), Indication (Lung Cancer, Breast Cancer, Prostate Cancer and Others), Sample Type (Blood, Urine, Saliva, and Others), Clinical Applications (Diagnosis & Screening, Treatment Selection, Drug Resistance, Prognosis, and Others), End-user (Hospitals & Laboratories, Specialty Clinics, Academic & Research Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

Increasing Oncology Diagnosis and Sustainable Practices:

• The future trends of liquid biopsy are depending on oncology diagnosis techniques. Liquid biopsy has various advantages over traditional biopsy methods because liquid biopsy is non-invasive, helps for personalize treatment and provides real-time information. It helps to detect and monitor cancer in several body fluids and also tumor tissue.  Also, it detects early stage of cancer and examines disease progression. For various types of cancers like prostate cancer, lung cancer and breast cancer, liquid biopsy is used for diagnostics and screening and also gives ancestral history of patients. Thus increasing demand for cancer screening tests, manufactures focused on developing new techniques and extensive application.